3:30
Carl Heneghan - There's a problem with understanding risk, uncertainty and evidence.
3:15
Albert Bosch - SARS-CoV-2 detected in a wastewater sample of March 12th 2019 in Barcelona
5:02
Antonio Bertoletti - Do we really have a Cytokine Release Syndrome in COVID-19 patients?
1:17:49
Karl J. Friston - An introduction to dynamic causal modelling and its use in the COVID-19 pandemic
4:00
Karl J. Friston - Heterogeneity - A model where SARS-CoV-2 transmission occurs only in 12,5%
1:18
Johann Giesecke - “most people will not even be sick, they will not even notice they have it”
1:02
Hans-Georg Rammensee - Antibodies decrease is a completely normal process after a primary response
:39
Anne Johnson - An attack rate of 80% of the population (Fergusons model) was a very high estimate
1:00
Anders Tegnell - "You are immune if you have been diagnosed, surely for at least six months."
1:02
Antonio Bertoletti - Infections with betacoronaviruses are able to induce a good memory response
:48
Heneghan and Stadler on SARS 1 and Cross-reactivity - Evolution in Europe and Southeast Asia
2:50
Tom Jefferson - This would suggest that the viral spread was far larger earlier than what we thought
2:08
Shane Crotty - SARS2 reactive T cells in unexposed, normal healthy donors - Other Coronaviruses
2:37
Sunetra Gupta - There's a contagion of performance - Theater of the absurdest. Forgotten epidemics?
1:37
Gabriela Gomes - Heterogeneity in the population - A Threshold of ~10%-20% immunity avoids new waves
2:17
Alessandro Sette - Pre-existing immunity is detected in many non-exposed individuals
4:19
Beda Stadler - Cross-reactivity - The question of how many antibodies are providing immunity
1:49
Hans-Gustaf Ljunggren - T-cell immunity - Karolinska Institutet and K. University Hospital research
